US7115728B1
(en)
|
1995-01-30 |
2006-10-03 |
Ligand Pharmaceutical Incorporated |
Human peroxisome proliferator activated receptor γ
|
EP0930882A2
(en)
*
|
1996-08-02 |
1999-07-28 |
Institut Pasteur De Lille |
Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators
|
US20020006939A1
(en)
*
|
1997-10-13 |
2002-01-17 |
Smithkline Beecham P.L.C. |
Use of thiazolidinediones for the treatment of hyperglycaemia
|
US20010031776A1
(en)
*
|
1997-10-13 |
2001-10-18 |
Smithkline Beecham P.L.C. |
Use of thiazolidinediones for the treatment of hyperglycaemia
|
US6440961B1
(en)
|
1997-10-27 |
2002-08-27 |
Dr. Reddy's Research Foundation |
Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
US6369067B1
(en)
|
1997-10-27 |
2002-04-09 |
Dr. Reddy's Research Foundation |
Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
US6265401B1
(en)
|
1997-10-27 |
2001-07-24 |
Reddy-Cheminor, Inc. |
Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
US6444816B1
(en)
|
1997-10-27 |
2002-09-03 |
Dr. Reddy's Research Foundation |
Fused 7-oxo-pyrimidinyl compounds, preparation, composition and use thereof
|
BR9812770A
(pt)
|
1997-10-27 |
2000-12-12 |
Reddy Research Foundation |
Compostos bicìclicos, processo para seu preparo e composições farmacêuticas contendo os mesmos
|
EP1124807A1
(en)
|
1997-10-27 |
2001-08-22 |
Dr. Reddy's Research Foundation |
Novel heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
AU749505B2
(en)
*
|
1997-10-27 |
2002-06-27 |
Dr. Reddy's Laboratories Limited |
Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
|
US7517884B2
(en)
|
1998-03-30 |
2009-04-14 |
Kalypsys Inc. |
Sulfonyl-substituted bicyclic compounds as modulators of PPAR
|
AR029876A1
(es)
|
1998-05-11 |
2003-07-23 |
Takeda Pharmaceutical |
Compuesto de acido oxiiminoalcanoilo, composicion farmaceutica y agente para controlar receptores relacionados con retinoide que lo comprenden y su uso
|
WO2000023417A1
(en)
*
|
1998-10-21 |
2000-04-27 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
US6248781B1
(en)
|
1998-10-21 |
2001-06-19 |
Novo Nordisk A/S |
Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
|
AU6325799A
(en)
*
|
1998-10-21 |
2000-05-08 |
Dr. Reddy's Research Foundation |
New compounds, their preparation and use
|
US6300339B1
(en)
|
1998-10-21 |
2001-10-09 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
US6365586B1
(en)
|
1998-10-21 |
2002-04-02 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
US6468996B1
(en)
|
1998-10-21 |
2002-10-22 |
Novo Nordisk A/S |
Substituted hetero-polycyclic compounds as PPARα and PPARγ activators
|
WO2000023415A1
(en)
*
|
1998-10-21 |
2000-04-27 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
US6214820B1
(en)
|
1998-10-21 |
2001-04-10 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
JP2002527502A
(ja)
*
|
1998-10-21 |
2002-08-27 |
ノボ ノルディスク アクティーゼルスカブ |
新規化合物、それらの調製及び使用
|
AU6325599A
(en)
*
|
1998-10-21 |
2000-05-08 |
Dr. Reddy's Research Foundation |
New compounds, their preparation and use
|
JP2002527507A
(ja)
*
|
1998-10-21 |
2002-08-27 |
ノボ ノルディスク アクティーゼルスカブ |
新規化合物類、それらの調製及び使用
|
EP1171431A1
(en)
*
|
1999-04-20 |
2002-01-16 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
US6369055B1
(en)
|
1999-04-20 |
2002-04-09 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
US6274608B1
(en)
|
1999-04-20 |
2001-08-14 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
US7414128B2
(en)
|
1999-04-20 |
2008-08-19 |
Dr. Reddy's Laboratories, Limited |
Crystalline R-guanidines, Arginine or (L)-Arginine (2S)-2-Ethoxy-3-{4-[2-(10H -phenoxazin-10-yl)ethoxy]phenyl}propanoate
|
EP1171414A1
(en)
*
|
1999-04-20 |
2002-01-16 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
US6972294B1
(en)
|
1999-04-20 |
2005-12-06 |
Novo Nordisk, A/S |
Compounds, their preparation and use
|
AU3958100A
(en)
*
|
1999-04-20 |
2000-11-02 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
NZ515284A
(en)
*
|
1999-04-28 |
2004-12-24 |
Dr |
Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
|
JP4618845B2
(ja)
|
1999-06-09 |
2011-01-26 |
杏林製薬株式会社 |
ヒトペルオキシゾーム増殖薬活性化受容体(PPAR)αアゴニストとしての置換フェニルプロピオン酸誘導体
|
ES2204684T3
(es)
|
1999-08-27 |
2004-05-01 |
Eli Lilly And Company |
Derivados de biaril-oxa(tia)zol y su uso como modulares de ppar.
|
US6414002B1
(en)
|
1999-09-22 |
2002-07-02 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
IL139197A0
(en)
|
1999-10-29 |
2001-11-25 |
Pfizer Prod Inc |
Use of corticotropin releasing factor antagonists and related compositions
|
US7323496B2
(en)
|
1999-11-08 |
2008-01-29 |
Theracos, Inc. |
Compounds for treatment of inflammation, diabetes and related disorders
|
US6525093B1
(en)
*
|
1999-11-08 |
2003-02-25 |
Calyx Therapeutics Inc. |
Compounds to treat diabetes and associated conditions
|
EP1250323B1
(en)
*
|
2000-01-19 |
2014-01-01 |
Cadila Healthcare Limited |
Compounds having hypolipidemic and hypocholesterolemic activities, process for their preparation and pharmaceutical compositions containing them
|
US6555577B1
(en)
|
2000-01-28 |
2003-04-29 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
US6569901B2
(en)
|
2000-01-28 |
2003-05-27 |
Novo Nordisk A/S |
Alkynyl-substituted propionic acid derivatives, their preparation and use
|
CA2396372A1
(en)
*
|
2000-01-28 |
2001-08-02 |
Novo Nordisk A/S |
Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity
|
US6509374B2
(en)
|
2000-04-17 |
2003-01-21 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
EP1348698A4
(en)
*
|
2000-12-05 |
2005-01-19 |
Kyorin Seiyaku Kk |
SUBSTITUTED CARBOXYLENE DERIVATIVES
|
US6982251B2
(en)
*
|
2000-12-20 |
2006-01-03 |
Schering Corporation |
Substituted 2-azetidinones useful as hypocholesterolemic agents
|
US7071181B2
(en)
*
|
2001-01-26 |
2006-07-04 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
|
AR035533A1
(es)
*
|
2001-01-26 |
2004-06-02 |
Schering Corp |
Uso de por lo menos un inhibidor de la absorcion de los esteroles o sus sales, solvatos, prodrogas farmaceuticamente aceptables o mezclas de los mismos para la preparacion de un medicamento para el tratamiento de la sitosterolemia, composiciones farmaceuticas, el uso de dichas composiciones para la
|
US20020151536A1
(en)
*
|
2001-01-26 |
2002-10-17 |
Schering Corporation |
Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
|
CA2434488A1
(en)
*
|
2001-01-26 |
2002-08-01 |
Harry R. Davis |
Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
|
EP1911462A3
(en)
|
2001-01-26 |
2011-11-30 |
Schering Corporation |
Compositions comprising a sterol absorption inhibitor
|
CA2434033A1
(en)
*
|
2001-01-26 |
2002-08-01 |
Schering Corporation |
Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
|
SK9502003A3
(en)
*
|
2001-01-26 |
2003-12-02 |
Schering Corp |
Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
|
EP1385548B1
(en)
*
|
2001-01-26 |
2007-05-23 |
Schering Corporation |
Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
|
US20050054730A1
(en)
*
|
2001-03-27 |
2005-03-10 |
The Regents Of The University Of California |
Compounds, compositions and treatment of oleoylethanolamide-like modulators of PPARalpha
|
FR2822955B1
(fr)
*
|
2001-03-27 |
2003-10-03 |
Chru Lille |
Methode de diagnostic de maladies inflammatoires chroniques de l'intestin
|
DK1392295T3
(da)
|
2001-05-15 |
2006-10-02 |
Hoffmann La Roche |
Carboxylsyre-substituerede oxazol-derivater til anvendelse som PPAR-alpha og -gamma-aktivatorer i behandlingen af diabetes
|
AR038956A1
(es)
*
|
2001-05-25 |
2005-02-02 |
Schering Corp |
Uso de un compuesto que regula la produccion o niveles de peptidos beta amiloides para la manufactura de un medicamento para tratar la enfermedad de alzheimer y/o para regular dichos niveles de peptidos amiloides beta en un sujeto
|
US6987123B2
(en)
*
|
2001-07-26 |
2006-01-17 |
Cadila Healthcare Limited |
Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
|
US7067530B2
(en)
|
2001-07-30 |
2006-06-27 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
US6869967B2
(en)
|
2001-07-30 |
2005-03-22 |
Novo Nordisk A/S |
Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives
|
JP2005504091A
(ja)
*
|
2001-09-21 |
2005-02-10 |
シェーリング コーポレイション |
ステロール吸収阻害剤としてアゼチジノンを用いる黄色腫の処置
|
US7056906B2
(en)
*
|
2001-09-21 |
2006-06-06 |
Schering Corporation |
Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
|
US7053080B2
(en)
*
|
2001-09-21 |
2006-05-30 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
|
US20030119808A1
(en)
*
|
2001-09-21 |
2003-06-26 |
Schering Corporation |
Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
|
US7220877B2
(en)
|
2001-10-17 |
2007-05-22 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
AU2002351752A1
(en)
|
2001-12-29 |
2003-07-30 |
Novo Nordisk A/S |
Combined use of a glp-1 compound and another drug for treating dyslipidemia
|
AU2003224632A1
(en)
*
|
2002-03-01 |
2003-09-16 |
Smithkline Beecham Corporation |
Hppars activators
|
US6716842B2
(en)
|
2002-04-05 |
2004-04-06 |
Warner-Lambert Company, Llc |
Antidiabetic agents
|
AU2003225027A1
(en)
*
|
2002-04-16 |
2003-11-03 |
Merck And Co., Inc. |
Combination therapy using a ppar alpha/gamma agonist
|
US6821524B2
(en)
*
|
2002-06-03 |
2004-11-23 |
Jan Marini Skin Research, Inc. |
Cosmetic skin care compositions
|
KR100621294B1
(ko)
|
2002-07-03 |
2006-09-06 |
에프. 호프만-라 로슈 아게 |
옥사졸 유도체 및 이의 인슐린 증감제로서의 용도
|
CN100475810C
(zh)
*
|
2002-08-30 |
2009-04-08 |
霍夫曼-拉罗奇有限公司 |
作为PPARα和PPARγ激动剂的新型2-芳基噻唑化合物
|
PL375878A1
(en)
|
2002-09-12 |
2005-12-12 |
F.Hoffmann-La Roche Ag |
N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes
|
ATE405560T1
(de)
|
2002-11-25 |
2008-09-15 |
Hoffmann La Roche |
Indolderivaten
|
US7192970B2
(en)
|
2002-11-26 |
2007-03-20 |
Chipscreen Biosciences, Ltd. |
Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity
|
US7816385B2
(en)
|
2002-12-20 |
2010-10-19 |
High Point Pharmaceuticals, Llc |
Dimeric dicarboxylic acid derivatives, their preparation and use
|
US6653334B1
(en)
|
2002-12-27 |
2003-11-25 |
Kowa Co., Ltd. |
Benzoxazole compound and pharmaceutical composition containing the same
|
MXPA05009503A
(es)
|
2003-03-07 |
2005-10-18 |
Schering Corp |
Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
|
US7208486B2
(en)
|
2003-03-07 |
2007-04-24 |
Schering Corporation |
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
|
DE602004002394T2
(de)
*
|
2003-04-17 |
2007-09-13 |
Kalypsys, Inc., San Diego |
(3-{3-'(2,4-bis-trifluormethyl-benzyl)-(5-ethyl-pyrimidin-2-yl)-amino]-propoxy}-phenyl)-essigsäure und verwandte verbindungen als modulatoren von ppars und verfahren zur behandlung von stoffwechselstörungen
|
US20050182125A1
(en)
*
|
2003-05-16 |
2005-08-18 |
Ambit Biosciences Corporation |
Pyrrole compounds and uses thereof
|
US20040248972A1
(en)
*
|
2003-05-16 |
2004-12-09 |
Ambit Biosciences Corporation |
Compounds and uses thereof
|
WO2004103959A2
(en)
*
|
2003-05-16 |
2004-12-02 |
Ambit Biosciences Corporation |
Heterocyclic compounds and uses thereof
|
KR20070050475A
(ko)
*
|
2004-08-11 |
2007-05-15 |
교린 세이야꾸 가부시키 가이샤 |
신규 환상 아미노 안식향산 유도체
|
WO2006055187A1
(en)
|
2004-10-29 |
2006-05-26 |
Kalypsys, Inc. |
Sulfonyl-substituted bicyclic compounds as modulators of ppar
|
WO2006082495A1
(en)
*
|
2005-02-02 |
2006-08-10 |
Ranbaxy Laboratories Limited |
Peroxisome proliferator activated receptor modulators
|
ITRM20050390A1
(it)
*
|
2005-07-22 |
2007-01-23 |
Giuliani Spa |
Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
|
ITRM20050389A1
(it)
|
2005-07-22 |
2007-01-23 |
Giuliani Spa |
Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
|
HUE040020T2
(hu)
|
2005-10-25 |
2019-02-28 |
Kalypsys Inc |
PPAR modulátorok sói és eljárások metabolikus betegségek kezelésére
|
DK1976509T3
(en)
|
2006-01-18 |
2015-03-23 |
Evolva Sa |
PPAR modulators
|
US8217025B2
(en)
*
|
2006-11-17 |
2012-07-10 |
Harbor Therapeutics, Inc. |
Drug screening and treatment methods
|
US20100273824A1
(en)
|
2007-01-18 |
2010-10-28 |
Evolva Sa |
Substituted 1,3-dioxanes and their uses
|
JP2010516702A
(ja)
|
2007-01-18 |
2010-05-20 |
エヴォルヴァ エスアー |
置換1,3−ジオキサンのプロドラッグおよびそれらの使用
|
US20080176861A1
(en)
|
2007-01-23 |
2008-07-24 |
Kalypsys, Inc. |
Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis
|
UA107562C2
(uk)
|
2008-12-05 |
2015-01-26 |
|
Спосіб лікування псоріазу
|
JP5715070B2
(ja)
|
2009-02-16 |
2015-05-07 |
ノグラ ファーマ リミテッド |
アルキルアミド化合物およびその使用
|
US20130156720A1
(en)
|
2010-08-27 |
2013-06-20 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
SI2670486T1
(sl)
|
2011-01-31 |
2016-09-30 |
Cadila Healthcare Limited Zydus Tower Satellite Cross Roads |
Zdravljenje lipodistrofije
|
CA2864059C
(en)
|
2012-02-09 |
2020-04-28 |
Nogra Pharma Limited |
Methods of treating fibrosis
|
MX2014012652A
(es)
|
2012-04-18 |
2014-11-25 |
Nogra Pharma Ltd |
Metodo de tratamiento de la intolerancia a la lactosa.
|
AU2013387996B2
(en)
|
2013-04-22 |
2015-12-10 |
Cadila Healthcare Limited |
A novel composition for nonalcoholic fatty liver disease (NAFLD)
|
WO2014195967A2
(en)
|
2013-05-30 |
2014-12-11 |
Cadila Healthcare Limited |
A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities
|
TW201636015A
(zh)
|
2013-07-05 |
2016-10-16 |
卡地拉保健有限公司 |
協同性組成物
|
IN2013MU02470A
(pt)
|
2013-07-25 |
2015-06-26 |
Cadila Healthcare Ltd |
|
IN2013MU02905A
(pt)
|
2013-09-06 |
2015-07-03 |
Cadila Healthcare Ltd |
|
US10385017B2
(en)
|
2015-10-14 |
2019-08-20 |
Cadila Healthcare Limited |
Pyrrole compound, compositions and process for preparation thereof
|
BR112019011740A2
(pt)
|
2016-12-09 |
2019-10-29 |
Cadila Healthcare Ltd |
composição farmacêutica e método para o tratamento de colangite biliar primária
|
AU2020217884A1
(en)
|
2019-02-08 |
2021-08-12 |
Nogra Pharma Limited |
Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof
|